A Comprehensive Literature Review of Digital Health Interventions in the Treatment of Substance Use Disorder With Special Focus on Mobile Applications.
Autor: | Jordan HR; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA., Sahni S; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA., Ahmed MM; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA., Fares JE; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA., Desai BV; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA., Lenchur CN; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA., Jermyn RT; Medicine, NeuroMusculoskeletal Institute, Rowan Medicine, Stratford, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cureus [Cureus] 2023 Oct 25; Vol. 15 (10), pp. e47639. Date of Electronic Publication: 2023 Oct 25 (Print Publication: 2023). |
DOI: | 10.7759/cureus.47639 |
Abstrakt: | COVID-19 quarantine showed an increase in opioid-related deaths partially due to the limited capacity of clinics and treatment centers. Digital health interventions (DHIs) such as telehealth have improved access to treatment, reduced psychosocial barriers, and helped patients with substance use disorder (SUD). An in-depth literature review was conducted to gauge the efficacy and usefulness of DHIs on substance use disorder. PubMed was used with string search terms to identify studies analyzing telehealth for substance use disorders. Studies were eligible and selected if they used health interventions (HIs) and reported outcomes on the efficacy of DHIs, benefits of DHIs, and limitations of DHIs. The Agency of Healthcare Research and Quality (AHRQ) was used to analyze the impact of DHIs on SUD. Lastly, Apple's App Store was used to identify the current DHI available. The analysis indicated that mobile phone apps were the most appropriate sources to use for patients with substance use disorders. The search also found 36 mobile applications available on the market for patients, containing mainly pain medication diaries and trackers. The study did not find any apps for clinical usage that met the standards necessary for adequate healthcare in the opioid crisis, largely due to a lack of clinician involvement in using applications. Developing adequate DHIs has the potential to improve outcomes in patients with SUD and aid in recovery time. The research concluded that physicians looking to develop DHIs should take into consideration the mode of delivery of DHI, the aim to produce specific health outcomes as opposed to multiple outcomes, and clinician involvement in DHI development. DHIs can become a vital tool for medical professionals, especially during the COVID-19 crisis, as the use of healthcare technology has limited in-person contact, maintained current doctor-patient relationships, and allowed for contact tracing of the disease. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Jordan et al.) |
Databáze: | MEDLINE |
Externí odkaz: |